S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.15 (-1.89%)
NIO   3.86 (-3.50%)
BABA   68.73 (-0.22%)
T   16.41 (+0.49%)
F   12.16 (+0.83%)
MU   110.00 (-1.72%)
GE   152.44 (-0.33%)
CGC   8.11 (+3.58%)
DIS   112.24 (-0.17%)
AMC   3.04 (+4.11%)
PFE   25.48 (+0.35%)
PYPL   62.12 (+0.03%)
XOM   120.24 (+1.45%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.15 (-1.89%)
NIO   3.86 (-3.50%)
BABA   68.73 (-0.22%)
T   16.41 (+0.49%)
F   12.16 (+0.83%)
MU   110.00 (-1.72%)
GE   152.44 (-0.33%)
CGC   8.11 (+3.58%)
DIS   112.24 (-0.17%)
AMC   3.04 (+4.11%)
PFE   25.48 (+0.35%)
PYPL   62.12 (+0.03%)
XOM   120.24 (+1.45%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.15 (-1.89%)
NIO   3.86 (-3.50%)
BABA   68.73 (-0.22%)
T   16.41 (+0.49%)
F   12.16 (+0.83%)
MU   110.00 (-1.72%)
GE   152.44 (-0.33%)
CGC   8.11 (+3.58%)
DIS   112.24 (-0.17%)
AMC   3.04 (+4.11%)
PFE   25.48 (+0.35%)
PYPL   62.12 (+0.03%)
XOM   120.24 (+1.45%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.15 (-1.89%)
NIO   3.86 (-3.50%)
BABA   68.73 (-0.22%)
T   16.41 (+0.49%)
F   12.16 (+0.83%)
MU   110.00 (-1.72%)
GE   152.44 (-0.33%)
CGC   8.11 (+3.58%)
DIS   112.24 (-0.17%)
AMC   3.04 (+4.11%)
PFE   25.48 (+0.35%)
PYPL   62.12 (+0.03%)
XOM   120.24 (+1.45%)
Free Trial

AtriCure (ATRC) Earnings Date, Estimates & Call Transcripts

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free ATRC Stock Alerts
$23.15
-0.24 (-1.03%)
(As of 10:11 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
May. 1
After Market Closes
Confirmed
Actual EPS
(Feb. 15)
-$0.21 Beat By $0.01
Consensus EPS
(Feb. 15)
-$0.22
Read Call Transcript
Listen to Call
Latest SEC 10-Q Filing
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ATRC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ATRC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AtriCure Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241($0.24)($0.24)($0.24) 
Q2 20241($0.23)($0.23)($0.23) 
Q3 20241($0.20)($0.20)($0.20) 
Q4 20241($0.16)($0.16)($0.16) 
FY 20244($0.83)($0.83) ($0.83)

ATRC Earnings Date and Information

AtriCure last posted its quarterly earnings results on February 15th, 2024. The medical device company reported ($0.21) EPS for the quarter, beating analysts' consensus estimates of ($0.22) by $0.01. The business had revenue of $106.50 million for the quarter, compared to analyst estimates of $103.68 million. Its revenue was up 21.0% on a year-over-year basis. AtriCure has generated ($0.66) earnings per share over the last year (($0.66) diluted earnings per share). Earnings for AtriCure are expected to grow in the coming year, from ($0.71) to ($0.47) per share. AtriCure has confirmed that its next quarterly earnings report will be published on Wednesday, May 1st, 2024. AtriCure will be holding an earnings conference call on Wednesday, May 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call..

AtriCure Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2024
Confirmed)		-------  
2/15/2024Q4 2023($0.22)($0.21)+$0.01($0.21)$103.68 million$106.50 million      
11/1/2023Q3 2023($0.30)($0.20)+$0.10($0.20)$96.65 million$98.29 million      
7/25/2023Q2 2023($0.27)($0.12)+$0.15($0.13)$97.55 million$100.92 million    
5/2/2023Q1 2023($0.34)($0.23)+$0.11($0.32)$87.53 million$93.49 million      
2/21/2023Q4 2022($0.18)($0.09)+$0.09($0.09)$87.90 million$88.00 million      
11/1/2022Q3 2022($0.25)($0.27)($0.02)($0.27)$81.40 million$83.25 million
8/2/2022Q2 2022($0.30)($0.32)($0.02)($0.32)$79.55 million$84.53 million      
5/3/2022Q1 2022($0.33)($0.33)-($0.33)$71.17 million$74.58 million      
2/15/2022Q4 2021($0.26)($0.30)($0.04)($0.30)$72.50 million$73.22 million    
11/3/2021Q3 2021($0.28)$2.11+$2.39($2.57)$68.95 million$70.46 million    
8/3/2021Q2 2021($0.30)($0.36)($0.06)($0.24)$61.08 million$71.38 million  
4/26/2021Q1 2021($0.38)($0.38)-($0.26)$56.24 million$59.28 million  

AtriCure Earnings - Frequently Asked Questions

When is AtriCure's earnings date?

AtriCure has confirmed that its next quarterly earnings data will be published on Wednesday, May 1st, 2024. Learn more on ATRC's earnings history.

Did AtriCure beat their earnings estimates last quarter?

In the previous quarter, AtriCure (NASDAQ:ATRC) reported ($0.21) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.22) by $0.01. Learn more on analysts' earnings estimate vs. ATRC's actual earnings.

How can I listen to AtriCure's earnings conference call?

The conference call for AtriCure's latest earnings report can be listened to online. Listen to Conference Call

How can I read AtriCure's conference call transcript?

The conference call transcript for AtriCure's latest earnings report can be read online. Read Transcript

How can I view AtriCure's earnings report?

AtriCure's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does AtriCure generate each year?

AtriCure (NASDAQ:ATRC) has a recorded annual revenue of $399.24 million.

How much profit does AtriCure generate each year?

AtriCure (NASDAQ:ATRC) has a recorded net income of -$30.44 million. ATRC has generated -$0.66 earnings per share over the last four quarters.

What is AtriCure's EPS forecast for next year?

AtriCure's earnings are expected to grow from ($0.71) per share to ($0.47) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:ATRC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative